NCT05868551

Brief Summary

This is an exploratory case control study with the aim to compare the Onchocerca volvulus virome between persons with onchocerciasis-associated epilepsy (OAE) and persons with onchocerciasis but without epilepsy. The main question we want to address is: Is there a virus contained in the O. volulus worm that may have a pathogenic role in causing OAE. In Maridi County, South Sudan, 20 persons with OAE with onchocerciasis nodules, and 20 age- and village-matched controls without OAE will be enrolled in a nodulectomy study.The adult O. volvulus worms will be extracted from the nodules and a viral metagenomic study of the worms. The O. volvulus virome of persons with and without OAE will be compared.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 22, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 22, 2023

Status Verified

May 1, 2023

Enrollment Period

1.1 years

First QC Date

May 8, 2023

Last Update Submit

May 17, 2023

Conditions

Keywords

OnchocerciasisEpilepsymetagenomicsSouth SudanPathogenesis

Outcome Measures

Primary Outcomes (1)

  • The O. volvulus virome of persons with onchocerciasis-associated epilepsy (OAE) and of persons with onchocerciasis but without epilepsy

    The type of virusses present in the O. volvulus worm present in the nodules of persons with OAE and in nodules of persons without epilepsy

    1 day

Study Arms (1)

Persons with onchocerciasis nodules with OAE and without epilepsy

nodulectomy to extract adult worms

Procedure: nodulectomy

Interventions

nodulectomyPROCEDURE

incision in an onchocerciasis nodule to extract adult worms

Persons with onchocerciasis nodules with OAE and without epilepsy

Eligibility Criteria

Age12 Years - 35 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Cases: persons with onchocerciasis nodules and OAE Controls: persons with onchocerciasis nodules without epilepsy

You may qualify if:

  • Onchocerciasis nodules
  • Age 12-35 years old
  • informed consent signed
  • Living in Maridi County, Western Equatorial State, South Sudan

You may not qualify if:

  • below the age of 12

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amref Health Africa

Juba, Central, 140, South Sudan

Location

Related Publications (1)

  • Hadermann A, Jada SR, Sebit WJ, Deng T, Bol YY, Siewe Fodjo JN, De Coninck L, Matthijnssens J, Mertens I, Polman K, Colebunders R. Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on Onchocerca volvulus. F1000Res. 2023 Dec 11;12:1262. doi: 10.12688/f1000research.138774.2. eCollection 2023.

Biospecimen

Retention: SAMPLES WITH DNA

skin snips O.volvulus worms

MeSH Terms

Conditions

EpilepsyVirus DiseasesOnchocerciasis

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesInfectionsFilariasisSpirurida InfectionsSecernentea InfectionsNematode InfectionsHelminthiasisParasitic DiseasesSkin Diseases, ParasiticSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Robert Colebunders, MD

    Universiteit Antwerpen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jean Pierre Van geertruyden, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Emeritus professor, head NSETHIO research group, Global Health institute

Study Record Dates

First Submitted

May 8, 2023

First Posted

May 22, 2023

Study Start

June 1, 2023

Primary Completion

July 1, 2024

Study Completion

December 31, 2024

Last Updated

May 22, 2023

Record last verified: 2023-05

Locations